GlaxoSmithKline has chosen Emma Walmsley, head of consumer healthcare, as its new chief executive. Both internal and external candidates were considered for the position. Walmsley first joined GlaxoSmithKline in 2010 from L’Oreal and will replace Andrew Witty. As Chairman Philip Hampton said,

“Under Andrew’s leadership, GSK has successfully developed into a company with market-leading positions in pharmaceuticals, vaccines and consumer healthcare.  These provide excellent platforms for sustainable, long-term growth, and we are confident Emma will successfully build on these strengths.”